Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, I.
Right arrow Articles by Leichtman, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, I.
Right arrow Articles by Leichtman, A. B.

Journal of the American Society of Nephrology, Vol 6, 165-170, Copyright © 1995 by American Society of Nephrology

REVIEWS

Cholesterol emboli presenting as acute allograft dysfunction after renal transplantation

I Singh, PD Killen and AB Leichtman
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0364, USA.

Cholesterol emboli are a common complication of atherosclerotic vascular disease. A 40-yr-old renal transplant recipient who developed acute allograft dysfunction 1 day after the initiation of cyclosporine therapy and 6 days after transplantation is described. A renal allograft biopsy revealed cholesterol emboli in interlobular arteries and in glomeruli. Four previously reported cases of cholesterol emboli in renal allografts are described, and the cause and pathogenesis of atheroembolic disease are reviewed. Atheroemboli causing injury to the renal allograft may arise from either donor or recipient vessels. Vigilance for the occurrence of these emboli needs to be maintained when donor or recipient vessels demonstrate evidence of significant atherosclerotic vascular disease.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
C. Sommerer, R. Waldherr, and C. Morath
Rapid deterioration of renal function in a long-term allograft recipient with recurrent IgA nephritis is it the only cause?
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3079 - 3081.
[Full Text] [PDF]

Home page
 CMAJHome page
G. Knoll, S. Cockfield, T. Blydt-Hansen, D. Baran, B. Kiberd, D. Landsberg, D. Rush, E. Cole, and for The Kidney Transplant Working Group of the Can
Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation
Can. Med. Assoc. J., November 8, 2005; 173(10): S1 - S25.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. S. MODI and V. K. RAO
Atheroembolic Renal Disease
J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1781 - 1787.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673